← All companies

IMCR

Immunocore Holdings plc

IMCR Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗

$32.43

-1.44 -4.25%

Key statistics

from XBRL data in SEC filings

Market cap

$1.65B

Revenue (TTM)

$413M

Net income (TTM)

-$27.6M

EPS (TTM)

$-0.56

P/E ratio

—

Dividend yield

—

Free cash flow

-$15.1M

Cash

$453M

Total assets

$1.07B

Gross margin

—

52-week range

$27.56 – $40.72

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Shareholder vote results May 27, 2026 8-K Results of operations (earnings release) May 6, 2026 10-Q Quarter ended 2026-03-31 May 6, 2026 8-K Results of operations (earnings release) Feb 25, 2026 10-K Fiscal year ended 2025-12-31 Feb 25, 2026 8-K Director or officer change Jan 30, 2026 8-K Results of operations (earnings release); Regulation FD disclosure; Other events Jan 9, 2026 8-K Director or officer change Nov 28, 2025 8-K Results of operations (earnings release) Nov 6, 2025 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release) Aug 7, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Shareholder vote results May 15, 2025 8-K Results of operations (earnings release) May 7, 2025 10-Q Quarter ended 2025-03-31 May 7, 2025 8-K Other events Mar 17, 2025 8-K Regulation FD disclosure Mar 10, 2025 8-K Results of operations (earnings release); Director or officer change Feb 26, 2025 10-K Fiscal year ended 2024-12-31 Feb 26, 2025 8-K Results of operations (earnings release); Regulation FD disclosure; Other events Jan 10, 2025 8-K Director or officer change; Regulation FD disclosure Jan 2, 2025 8-K Terminated a material agreement Nov 8, 2024 8-K Results of operations (earnings release) Nov 6, 2024 10-Q Quarter ended 2024-09-30 Nov 6, 2024 8-K Other events Sep 16, 2024 8-K Director or officer change; Regulation FD disclosure Aug 29, 2024 8-K Results of operations (earnings release) Aug 8, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Regulation FD disclosure May 31, 2024 8-K Other events May 30, 2024 8-K Entered a material agreement; Director or officer change May 28, 2024 8-K Shareholder vote results May 23, 2024 8-K Results of operations (earnings release) May 8, 2024 10-Q Quarter ended 2024-03-31 May 8, 2024 8-K Other events Apr 5, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Feb 28, 2024 10-K Fiscal year ended 2023-12-31 Feb 28, 2024 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Other events Feb 2, 2024 8-K Results of operations (earnings release); Other events Jan 29, 2024 8-K Results of operations (earnings release); Regulation FD disclosure; Other events Jan 5, 2024